Personalizing risk stratification by addition of PAK1 expression to TNM staging: Improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Personalizing risk stratification by addition of PAK1 expression to TNM staging: Improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 136, Issue 7, Pages 1636-1645
Publisher
Wiley
Online
2014-08-27
DOI
10.1002/ijc.29167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Importance and Therapeutic Implications of PAK1, a Drugable Protein Kinase, in Gastroesophageal Junction Adenocarcinoma
- (2013) Zongtai Li et al. PLoS One
- Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II/III Junctional Adenocarcinoma
- (2012) Shinichi Hasegawa et al. ANNALS OF SURGICAL ONCOLOGY
- p21-activated kinases and gastrointestinal cancer
- (2012) Hong He et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The p21-activated kinase Pak1 regulates induction and migration of the neural crest in Xenopus
- (2012) Nicolas Bisson et al. CELL CYCLE
- Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--Opportunities, Challenges, and Limitations
- (2012) J. Eswaran et al. CLINICAL CANCER RESEARCH
- P21 Activated Kinase-1 (Pak1) Promotes Prostate Tumor Growth and Microinvasion via Inhibition of Transforming Growth Factor β Expression and Enhanced Matrix Metalloproteinase 9 Secretion
- (2012) Anna Goc et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- STE20-related Kinase Adaptor Protein α (STRADα) Regulates Cell Polarity and Invasion through PAK1 Signaling in LKB1-null Cells
- (2012) Carrie M. Eggers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor
- (2012) X Zhao et al. ONCOGENE
- PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells
- (2012) Matthew Rettig et al. PLoS One
- PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
- (2011) Y Shrestha et al. ONCOGENE
- Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array–comparative genomic hybridization
- (2010) Anna Isinger-Ekstrand et al. CANCER GENETICS AND CYTOGENETICS
- Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion
- (2010) Samantha K McCarty et al. ENDOCRINE-RELATED CANCER
- PAK1 as a therapeutic target
- (2010) Julia V Kichina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Signalling to cancer cell invasion through PAK family kinases
- (2010) Andrew Whale Frontiers in Bioscience-Landmark
- Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System
- (2010) Qin Huang et al. MODERN PATHOLOGY
- Positive lymph node retrieval ratio optimises patient staging in colorectal cancer
- (2009) S J Moug et al. BRITISH JOURNAL OF CANCER
- PAK signaling in oncogenesis
- (2009) P R Molli et al. ONCOGENE
- Multidisciplinary management of gastric and gastroesophageal cancers
- (2008) Markus Moehler et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Esophageal and Gastric Cardia Cancers on 4238 Chinese Patients Residing in Municipal and Rural Regions: A Histopathological Comparison During 24-Year Period
- (2008) Yu Jing Fan et al. WORLD JOURNAL OF SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now